OTCMKTS:BNVIQ - Bionovo Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$0.0003
Today's Range$0.0003 - $0.0003
52-Week Range$0.0003 - $0.0027
VolumeN/A
Average Volume96,632 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Bionovo, Inc. is a drug discovery and development company, which focuses on women's health and development of drugs for the treatment of cancer. The Company's drug candidates include Menerba, Seala, Bezielle, BN107 and BN108. Its Menerba is a selective estrogen receptor beta agonist, which reduces the frequency and severity of menopausal hot flashes. The Company has completed a randomized, double-blind, placebo-controlled Phase II clinical trial of Menerba. Bezielle is an orally delivered anti-cancer agent. The Company is engaged in an open label, multi-center Phase I/II trial of Bezielle for the treatment of advanced metastatic breast cancer. The Company's Seala is a selective estrogen receptor beta agonist, which acts as an intra-vaginal suppository. The Company's anti-cancer agents include BN107 and BN108, which are used for the treatment of advanced breast cancer. BN107 and BN108 are in pre-clinical development stage.

Receive BNVIQ News and Ratings via Email

Sign-up to receive the latest news and ratings for BNVIQ and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolOTCMKTS:BNVIQ
Previous SymbolNASDAQ:BNVI
CUSIPN/A
Phone+1-510-6012000

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
OptionableNot Optionable

Bionovo (OTCMKTS:BNVIQ) Frequently Asked Questions

What is Bionovo's stock symbol?

Bionovo trades on the OTCMKTS under the ticker symbol "BNVIQ."

Has Bionovo been receiving favorable news coverage?

Press coverage about BNVIQ stock has trended somewhat negative on Thursday, according to InfoTrie. The research group scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Bionovo earned a media sentiment score of -1.7 on InfoTrie's scale. They also gave news articles about the healthcare company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the next several days.

How do I buy shares of Bionovo?

Shares of BNVIQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bionovo's official website?

The official website for Bionovo is http://bionovo.com/.

How can I contact Bionovo?

Bionovo's mailing address is 5858 Horton St Ste 400, EMERYVILLE, CA 94608-2046, United States. The healthcare company can be reached via phone at +1-510-6012000.


MarketBeat Community Rating for Bionovo (OTCMKTS BNVIQ)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  38 (Vote Outperform)
Underperform Votes:  25 (Vote Underperform)
Total Votes:  63
MarketBeat's community ratings are surveys of what our community members think about Bionovo and other stocks. Vote "Outperform" if you believe BNVIQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BNVIQ will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/21/2019 by MarketBeat.com Staff

Featured Article: Fundamental Analysis

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel